JMPWA
RVNC

JP Morgan Private Wealth Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$623K Buy
54,329
+203
+0.4% +$3.9K ﹤0.01% 1152
2023
Q2 		$1.37M Sell
54,126
-1,684
-3% -$52.5K 0.01% 673
2023
Q1 		$1.8M Buy
55,810
+21,689
+64% +$676K ﹤0.01% 920
2022
Q4 		$630K Sell
34,121
-3,386
-9% -$77.5K ﹤0.01% 1367
2022
Q3 		$1.01M Buy
37,507
+9,529
+34% +$193K ﹤0.01% 1130
2022
Q2 		$387K Sell
27,978
-57,167
-67% -$880K ﹤0.01% 1550
2022
Q1 		$1.66M Sell
85,145
-27,299
-24% -$414K ﹤0.01% 979
2021
Q4 		$1.83M Sell
112,444
-52,662
-32% -$878K ﹤0.01% 942
2021
Q3 		$4.6M Buy
165,106
+10,756
+7% +$307K 0.01% 613
2021
Q2 		$4.58M Buy
154,350
+71,905
+87% +$2.07M 0.01% 616
2021
Q1 		$2.3M Buy
82,445
+38,251
+87% +$1.06M 0.01% 722
2020
Q4 		$1.25M Sell
44,194
-6,154
-12% -$159K ﹤0.01% 922
2020
Q3 		$1.27M Sell
50,348
-3,942
-7% -$103K ﹤0.01% 797
2020
Q2 		$1.33M Buy
54,290
+21,902
+68% +$432K 0.01% 705
2020
Q1 		$479K Buy
32,388
+14,038
+77% +$290K ﹤0.01% 943
2019
Q4 		$298K Buy
18,350
+3,708
+25% +$57.5K ﹤0.01% 1245
2019
Q3 		$190K Buy
14,642
+3,625
+33% +$44.4K ﹤0.01% 1352
2019
Q2 		$143K Buy
+11,017
New +$139K ﹤0.01% 1320

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Private Wealth Advisors's RVNC Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors increased its Revance Therapeutics, Inc. (RVNC) stake by 0.38% in Q3 2023, buying an estimated $3.9K and bringing the position to 54,329 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

JP Morgan Private Wealth Advisors first reported a position in RVNC in Q2 2019 and has held it in 18 quarters since. The position peaked at $4.6M in Q3 2021. 186 funds tracked by Wall St. Rank hold RVNC as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 54,329 shares of Revance Therapeutics, Inc. worth $623K as of Q3 2023.
  • JP Morgan Private Wealth Advisors bought 203 Revance Therapeutics, Inc. shares in Q3 2023, an estimated $3.9K.
  • Revance Therapeutics, Inc. made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1152 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Revance Therapeutics, Inc. in Q2 2019 and has held it in 18 quarters since.
  • JP Morgan Private Wealth Advisors's Revance Therapeutics, Inc. position peaked at $4.6M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.